Skip to Main Content

Paper Details

Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection.
Proc Natl Acad Sci U S A
63
2020
ACE2, COVID-19, Fab, IgG1 ab1, RBD, SARS-, SARS-CoV, SARS-CoV-2, SARS-CoV-2 infection, SARS-CoV-2 spike (S) glycoprotein, VH, ab1, ab1 sequence, ab1-like antibodies, hACE2, hACE2-expressing transgenic mice, human, human ACE2, mice, mouse, mouse ACE2-adapted SARS, phage-displayed, receptor binding domain, scFv, tissue culture
Author NameAffiliation
Lisa E GralinskiUniversity of North Carolina at Chapel Hill
Lisa E GralinskiUniversity of North Carolina at Chapel Hill
Alexandra Sch??ferUniversity of North Carolina at Chapel Hill
Sarah R LeistUniversity of North Carolina at Chapel Hill
Chien-Te K TsengGalveston National Laboratory
Ralph S BaricUniversity of North Carolina at Chapel Hill
Ralph S BaricUniversity of North Carolina at Chapel Hill
Dimiter S DimitrovCenter for Antibody Therapeutics, University of Pittsburgh Medical School
Dimiter S Dimitrov
  • 1 - 9

Datasets

Release 1.2